Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies - Schedule of Milestone Payment (Details)

v3.22.1
Commitments and Contingencies - Schedule of Milestone Payment (Details)
Dec. 31, 2021
USD ($)
Revenue Recognition Milestone Method [Line Items]  
Total potential milestone payments $ 5,625,000
First Dosing of Patient In U S Phase1 Trial  
Revenue Recognition Milestone Method [Line Items]  
Total potential milestone payments 250,000
US Phase 1 Trial Completion with Endpoints Met  
Revenue Recognition Milestone Method [Line Items]  
Total potential milestone payments 500,000
US Phase 2 Trial Completion with Endpoints Met  
Revenue Recognition Milestone Method [Line Items]  
Total potential milestone payments 875,000
FDA Approval  
Revenue Recognition Milestone Method [Line Items]  
Total potential milestone payments $ 4,000,000